ez5b00096_si_001.pdf (252 kB)
Download fileMethadone Contributes to N‑Nitrosodimethylamine Formation in Surface Waters and Wastewaters during Chloramination
journal contribution
posted on 2015-06-09, 00:00 authored by David Hanigan, E. Michael Thurman, Imma Ferrer, Yang Zhao, Susan Andrews, Jinwei Zhang, Pierre Herckes, Paul WesterhoffN-Nitrosodimethylamine
(NDMA) is a probable human
carcinogen that forms in drinking water as a disinfection byproduct.
Several specific precursor chemicals present during chloramination
are known but cannot account for the total observed NDMA formation
potential (FP) in drinking waters. We discovered a pharmaceutical
precursor of NDMA with high FP using a liquid chromatography/quadrupole/time-of-flight
mass spectrometry (LC/QTOF-MS) screening procedure. The pharmaceutical
methadone, which is used to mitigate heroin withdrawal symptoms and
is also prescribed for chronic pain, contains a dimethylisopropylamine
functional group that reacts to form large amounts of NDMA upon chloramination.
In this study, methadone had a molar NDMA yield ranging from 23 to
70% depending on chloramine dose (1–150 mg of Cl2/L) and was responsible for between 1 and 10% of NDMA FP in most
raw surface waters in which it was detected and up to 62% of NDMA
FP in wastewater. Samples with higher methadone concentrations had
greater NDMA FP. We measured a median methadone concentration of 23
ng/L with a range of 1–2256 ng/L among detections,
which was consistent with high occurrence rates
and environmental persistence for methadone in the published literature
for surface waters and wastewaters. A literature review of methadone
use, metabolism, and fate in the United States resulted in a prediction
of low nanogram per liter levels of methadone-associated NDMA FP at
drinking water treatment plants (DWTPs) downstream of communities
using methadone. Medicinal use of methadone potentially displaces
and transforms the health risks associated with heroin use by individuals
to possible cancer risk for populations served by downstream DWTPs.
This work is among the first to contrast known public health benefits
of pharmaceutical-taking patients against the potential exposure of
millions of people to physiologically relevant levels of carcinogenic
NDMA in chloraminated drinking water.